Johnson & Johnson said on Monday it has discontinued a late-stage study testing its experimental drug to treat a type of ...

“This was the invention of KarXT,” Dr. Miller said. In its submission of the drug for F.D.A. approval, Karuna cited a five-week study of 252 people with schizophrenia, half of whom were given ...

along with data from a Phase 3 study of its drug Uplizna in the treatment of generalized myasthenia gravis, or MG. The data was released in an online presentation posted to the company’s site ...

which could mean that more diverse study cohorts will be required in the future. The researchers also lacked individual patient data, and they did not include data on combination drugs or the use ...

Roche’s antiviral drug Xofluza reduced influenza transmission among household contacts in a large Phase 3 study, the company said Wednesday. Treatment with a single dose of Xofluza within 48 hours of ...

The newer and more expensive drugs rimegepant and ubrogepant — as well as another called lasmiditan, which can have drowsy side effects – were about as effective as paracetamol and anti-inflammatory ...

Another jury in the same courthouse handed a verdict last month to a separate Zantac manufacturer, GlaxoSmithKline. On May 23, an Illinois jury sided with both drug manufacturers in the first ...

By Brendan Pierson (Reuters) -The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, as jurors in Chicago were unable to agree ...

A Chicago jury failed to reach a verdict in the latest Zantac cancer trial involving Boehringer Ingelheim. Plaintiff Ronald Kimbrow claims the heartburn drug caused his prostate cancer. This marks the ...

Metformin, an inexpensive diabetes drug, slows ageing in male monkeys, particularly in their brain, according to a new study. The finding raises the possibility that the medication could one day be ...